Glibenclamide Alleviates LPS-Induced Acute Lung Injury through NLRP3 Inflammasome Signaling Pathway

Glibenclamide displays an anti-inflammatory response in various pulmonary diseases, but its exact role in lipopolysaccharide- (LPS-) induced acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) remains unknown. Herein, we aimed to explore the effect of glibenclamide in vivo and in v...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jie, Yang, Jiawen, Huang, Xiaofang, Xiu, Huiqing, Bai, Songjie, Li, Jiahui, Cai, Zhijian, Chen, Zhanghui, Zhang, Shufang, Zhang, Gensheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856806/
https://www.ncbi.nlm.nih.gov/pubmed/35185385
http://dx.doi.org/10.1155/2022/8457010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856806/
https://www.ncbi.nlm.nih.gov/pubmed/35185385
http://dx.doi.org/10.1155/2022/8457010

Ejemplares similares